About RxBiologics

RxBiologics is part of the RxCelerate group of companies. RxCelerate, was founded in 2013, with a vision to provide a bespoke high quality outsourced drug discovery and development platform. In 2018, RxCelerate made the decision to collaborate with Jonny Finlay, an experienced biotech antibody engineer, and invest in building from first principles a world-leading biologics antibody discovery platform to generate lead antibodies with the desired drug like properties from the beginning.

World-leading biologics antibody discovery

The RxBiologics Galaxy™ Antibody Discovery Platform together with RxCelerate biology, in-silico design, chemistry and programme management capabilities, enables us to deliver this vision for biologics drug discovery programmes.  We provide comprehensive work packages to support client projects from early discovery through preclinical phases.

Our Galaxy™ Platform

Galaxy™ is our proprietary library technology platform we now offer under RxBiologics.

Our Leadership Team

David Grainger

Co-founder & Executive Chairman

Following an academic career at Cambridge University leading a world-renowned group investigating the biology of chronic inflammation, David joined Index Ventures as a Venture Partner, before co-founding leading European Venture Capital house Medicxi.

Jill Reckless

Co-founder & Director

Co-founder and CEO of RxCelerate. Provides strategic vision to RxCelerate Group. Over 20 years’ experience of translational biology and leading drug discovery programmes covering a wide area of therapeutic indications.

Jonny Finlay

Co-founder & Director

Biotech entrepreneur with two decades of experience in biologics discovery and development in academia, government and pharma.

Nick Tait

CFO

Qualified Chartered Accountant trained at EY. Over 20 years’ experience of providing finance, investor relations and administrative support to companies.

Chris Rossant

Programme Director

Drug discovery scientist with 20 years plus experience in large pharma, biotechs and CRO’s providing leadership and management of biologics work programmes.

Yun Sanders

Team Manager

Experienced leader of multi-functional teams with extensive biologics and peptide discovery knowledge gained within the biotech sector.

Wei Li

Consultant Scientific Advisor

BHF Senior Research Fellow at University of Cambridge. Over 25 years’ experience in protein engineering, expression, purification and characterisation.

Home

Technology

Our Services

Contact Us

Antibody drug discovery services for rapid generation of world-class biologics with optimal drug development qualities

Get in touch

Call Us 01223 839557
Email Us info@rxbiologics.co.uk

Visit Us

B950 Dorothy Hodgkin Building,
Babraham Research Campus,
Babraham, Cambridge CB22 3FH